UCI’s $12M CIRM award for hNSC-01 marks a pivotal shift to clinical-stage development. See how this state-funded "bridge" is ...

Advances delivered what may feel like medical miracles, including the first bladder transplant, a lifesaving personalized ...

Instead of finding treatments for one rare disease, two University at Albany researchers have developed a compound that could ...

For the first time, scientists have successfully treated someone suffering from Huntington's disease, a fatal genetic illness ...

UniQure (NASDAQ:QURE) is one of the stocks that will double in 2026. On December 9, Mizuho analyst Uy Ear lowered the firm’s price target on uniQure to $33 from $60, while keeping an Outperform rating ...

An experimental gene therapy seems to slow the progression of Huntington’s disease by about 75 per cent, and researchers are ...

Huntingtons Disease Treatment Market size was valued at USD 457.5 million in 2023, with a projected CAGR of 20.8% over 2024-2032. This growth is fueled by the increasing prevalence of Huntington's ...

Huntington's is an inherited disease caused by a mutation in a single gene that causes a progressive breakdown of the brain's nerve cells. This degeneration in the brain may have a wide impact on a ...

PERRY, N.Y. — Reminders of Huntington’s disease populate Tammy Stewart’s apartment. They are also glimpses into her future. On the table beside the couch sit framed pictures of her dad, Roy, and one ...

Huntington’s disease is a genetic disease that is debilitating and progressive leading to severe brain damage and eventual death. In patients with this autosomal dominant disease, there is presence of ...